Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.
FEATURED PROJECTS

Finding Undiagnosed HIV:
Strategies From Community-Based Programs
Tuesday, September 19, 2017
1:00-2:00 pm ET

Register online at HIVEarlyTesting.com

Dr. Lisa B. Hightow-Weidman, Erik Valera from the Latino Commission on AIDS, and Barry Walters with AIDS Project New Haven, will present an accredited, educational, live webinar reviewing the incidence and sequelae associated with undetected HIV infection, identifying potential barriers to HIV screening, and evaluating strategies to promote HIV testing and counseling. In addition, they will discuss new techniques and technologies which can identify HIV infections to improve patient outcome.

Complimentary CME & CE Credits. There is no charge for the program or certificate, but registration is required for the webinar, access to the slides, and online post-test CME assessment.

Planned and developed by Medavera, Inc. and supported by Alere, Inc.

THE MEDICAL NEWS
(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding.... (Reuters Health) - Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers reported on Monday in a challenge to more conservative recommendations that take into account both the harms and the benefits of screening.... NEW YORK (Reuters) - Hikma Pharmaceuticals Plc's U.S. subsidiary has raised the price of a common diarrhea drug by more than 400 percent and is charging more for five other medicines as well, the Financial Times reported on Sunday.... SEOUL (Reuters) - Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs.... BOSTON (Reuters) - Insys Therapeutics Inc has agreed to pay $4.45 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses.... NEW DELHI (Reuters) - The Indian government has threatened Philip Morris International Inc with "punitive action" over the tobacco giant's alleged violation of the country's anti-smoking laws, according to a letter sent to the company by the federal health ministry.... (Reuters Health) - Women with anorexia nervosa or bulimia are up to four times more likely to be convicted of theft - often petty thefts like shoplifting - compared to peers without eating disorders, according to results from a large Swedish study.... (Reuters Health) - People with chronic low back pain may feel it even more sharply if their spouses are critical and unsupportive of their condition, according to a recent study.... BEIJING (Reuters) - China confirmed a bird flu outbreak at quail farms in the country's southwestern province of Guizhou, according to a Ministry of Agriculture statement on Friday.... BOSTON (Reuters) - Mylan NV has finalized a $465 million settlement resolving U.S. Justice Department claims it overcharged the government for its EpiPen emergency allergy treatment, which became the center of a firestorm over price increases....